Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial
by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient
Updated on: April 14,2024
18

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial
by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient
Updated on:April 14,2024
18
